A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy
A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy
Recruiting · NCT04663204 · Registry updated 2026-06-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder | Recruiting | Phase 2 | 2026-06-03 | NCT04663204 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Travere Therapeutics, Inc. | 10 |
| University of Leicester | 51 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cambridge University Hospitals NHS Trust | Cambridge | United Kingdom | 1 |
| King's College Hospital | London | United Kingdom | 45 |
| Leicester General Hospital, University Hospitals of Leicester NHS Trust | Leicester | United Kingdom | 1 |
| Northern Care Alliance NHS Foundation Trust - Salford Royal | Salford | United Kingdom | 1 |
| Royal Infirmary of Edinburgh & Western General Hospital | Edinburgh | United Kingdom | 1 |
| University Hospital of Wales | Cardiff | United Kingdom | 10 |